APA (7th ed.) Citation

Bruderer, S., Petersen-Sylla, M., Boehler, M., Remeňová, T., Halabi, A., & Dingemanse, J. (2017). Effect of Gemfibrozil on The Pharmacokinetics of Selexipag, An oral Prostacyclin Receptor Agonist, And Its Active Metabolite In Healthy Male Subjects. Clinical therapeutics, 39(8), e23-e24. https://doi.org/10.1016/j.clinthera.2017.05.072

Chicago Style (17th ed.) Citation

Bruderer, S., M. Petersen-Sylla, M. Boehler, T. Remeňová, A. Halabi, and J. Dingemanse. "Effect of Gemfibrozil on The Pharmacokinetics of Selexipag, An Oral Prostacyclin Receptor Agonist, And Its Active Metabolite In Healthy Male Subjects." Clinical Therapeutics 39, no. 8 (2017): e23-e24. https://doi.org/10.1016/j.clinthera.2017.05.072.

MLA (9th ed.) Citation

Bruderer, S., et al. "Effect of Gemfibrozil on The Pharmacokinetics of Selexipag, An Oral Prostacyclin Receptor Agonist, And Its Active Metabolite In Healthy Male Subjects." Clinical Therapeutics, vol. 39, no. 8, 2017, pp. e23-e24, https://doi.org/10.1016/j.clinthera.2017.05.072.